이상반응 보고
| VAERS ID | 1664947 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | FF4213 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-07-28 |
| 발병일 | 2021-07-29 |
| 상태 | 회복 |
증상
- 오한(Chills)
- 메스꺼움(Nausea)
- 실신(Malaise)
- 자연 낙태(Abortion spontaneous)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Miscarriage; COVID-19 vaccine exposure during pregnancy week: 3 weeks; Not feeling well; Cold shivers; Nausea; This is a spontaneous report from a contactable Consumer or other non HCP downloaded from the regulatory authority-WEB NL-LRB-00666784.
This is a maternal report.
A 35-year-old female patient received second dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: FF4213), via an unspecified route of administration on 28Jul2021 as DOSE 2, SINGLE for covid-19 immunisation.
The patient medical history and concomitant medications were not reported.
The patient previously received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection), via an unspecified route of administration on 22Jun2021 as DOSE 1, SINGLE for covid-19 immunisation and experienced no adverse event.
On 29Jul2021, the patient experienced miscarriage, covid-19 vaccine exposure during pregnancy week: 3 weeks, not feeling well, cold shivers, nausea.
One day after the vaccination, the miscarriage occurred.
Treatment: Maternal exposure during pregnancy is treated with Removal of the baby and miscarriage is treated with Removal of the baby.
The mother was 3 Weeks pregnant at the onset of the event.
The pregnancy resulted in spontaneous abortion.
Therapeutic measures were taken as a result of miscarriage, covid-19 vaccine exposure during pregnancy week: 3 weeks.
The outcome of events not feeling well, cold shivers, nausea were recovered on 31Jul2021 and other events were unknown at the time of report.
Health Authority Comment: Seriousness of miscarriage was changed from "death" to "other medically important condition".
Case summary: Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): yes ADRs: No Date: 22Jun2021, confounding factors: COVID-19 vaccine exposure during pregnancy week: 3 weeks.
Previous COVID-19 infection: No.
diagnostic procedures: I don't have the test results yet.
No follow-up attempts possible.
No further information expected.
; Reporter's Comments: Past drug therapy BioNTech/Pfizer vaccine (Comirnaty): yes ADRs: No Date: 22Jun2021, confounding factors: COVID-19 vaccine exposure during pregnancy week: 3 weeks.
Previous COVID-19 infection: No.
diagnostic procedures: I don't have the test results yet